Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-01-06FDA Approved: OMEGA-3-ACID ETHYL ESTERS — Supplemental Application (KD Pharma USA, Inc.)
The FDA approved a supplemental application for Omega-3-acid ethyl esters from KD Pharma USA, Inc., confirming continued approval of this ge…
-
FDA approval · 2020-12-17FDA Approved: EZETIMIBE AND SIMVASTATIN — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's original-application generic fixed-dose combination of ezetimibe and simvastatin.
-
FDA approval · 2020-12-15FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for the fixed-dose combination of amlodipine besylate and atorvastatin calcium, manufactured by …
-
FDA approval · 2020-12-10FDA Approved: LOPID — Supplemental Application (Parke-Davis Div of Pfizer Inc)
FDA approved a supplemental application for Lopid (gemfibrozil) submitted by Parke-Davis Div of Pfizer Inc.
-
CLINICAL_TRIALS trial_result · 2020-11-12Clinical Trial Update: Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients [Phase 2]
Phase 2 pharmacokinetic study evaluating interactions between rosuvastatin and lopinavir/ritonavir in HIV patients with hyperlipidemia; comp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-10-28Clinical Trial Update: Trial to Evaluate the Effect of Inclisiran Treatment on Low Density Lipoprotein Cholesterol (LDL-C) in Subjects With Heterozygous Familial Hypercholesterolemia (HeFH) [Phase 3]
Phase 3 trial evaluating Inclisiran's effect on LDL-C in patients with heterozygous familial hypercholesterolemia has completed with results…
-
FDA approval · 2020-10-23FDA Approved: EZETIMIBE — Original Application (ScieGen Pharmaceuticals Inc)
FDA approved ScieGen Pharmaceuticals' original (ANDA) application for ezetimibe as a generic cholesterol-lowering medication.
-
FDA approval · 2020-10-19FDA Approved: FENOFIBRATE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic's generic fenofibrate under an original drug application, confirming its use for lipid disorders. Fenofibrate lowers tr…
-
FDA approval · 2020-10-13FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for ATORVASTATIN CALCIUM from Dr. Reddy's Laboratories Limited, granting approval for a generic ator…
-
FDA approval · 2020-09-25FDA Approved: ZYPITAMAG — Supplemental Application (Medicure International Inc)
The FDA has approved a supplemental application for ZYPITAMAG (pitavastatin magnesium) filed by Medicure International Inc.
-
FDA approval · 2020-09-25FDA Approved: EZALLOR SPRINKLE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical's supplemental application for EZALLOR SPRINKLE (rosuvastatin), adding a sprinkle formulation to the rosuvas…
-
FDA approval · 2020-09-25FDA Approved: VYTORIN — Supplemental Application (Organon LLC)
FDA approved a supplemental application for VYTORIN (ezetimibe and simvastatin) submitted by Organon LLC.
-
FDA approval · 2020-09-25FDA Approved: FLUVASTATIN — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for Fluvastatin (generic) under the ANDA.
-
FDA approval · 2020-09-25FDA Approved: LOVASTATIN — Supplemental Application (Carlsbad Technology, Inc.)
FDA approved a supplemental application for Lovastatin (Carlsbad Technology, Inc.) to modify an existing ANDA product.
-
FDA approval · 2020-09-25FDA Approved: FLUVASTATIN SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Fluvastatin Sodium (generic) filed by Mylan Pharmaceuticals Inc., enabling continued marketi…
-
FDA approval · 2020-09-15FDA Approved: FLUVASTATIN SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for fluvastatin sodium submitted by Mylan Pharmaceuticals, updating the approved ANDA product.
-
FDA approval · 2020-08-25FDA Approved: FENOFIBRATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Fenofibrate from Sun Pharmaceutical Industries, Inc.
-
CLINICAL_TRIALS trial_result · 2020-08-21Clinical Trial Update: Inclisiran for Subjects With ASCVD or ASCVD-Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol [Phase 3]
Phase 3 trial update for inclisiran in subjects with atherosclerotic cardiovascular disease or risk-equivalents and elevated LDL cholesterol…
-
FDA approval · 2020-08-19FDA Approved: ATORVASTATIN CALCIUM — Original Application (NIVAGEN PHARMACEUTICALS, INC.)
FDA approves an original new application for atorvastatin calcium from NIVAGEN Pharmaceuticals, a generic version of atorvastatin indicated …
-
CLINICAL_TRIALS trial_result · 2020-08-11Clinical Trial Update: Pharmacokinetic Study of Pitavastatin and Ritonavir-Boosted Darunavir or Efavirenz [Phase 1]
Phase 1 pharmacokinetic study investigating interactions between pitavastatin and ritonavir-boosted darunavir or efavirenz in hyperlipidemia…
-
CLINICAL_TRIALS trial_result · 2020-08-04Clinical Trial Update: Effects of Use of a Connected Pillbox On Medication Adherence [NA]
A completed clinical trial assessing how a connected pillbox affects medication adherence in patients with diabetes mellitus and hypertensio…
-
FDA label_change · 2020-07-29FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Welchol (colesevelam hydrochloride) to update the labeling and potentially expand its approved u…
-
FDA approval · 2020-07-29FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Welchol (colesevelam hydrochloride) from Cosette Pharmaceuticals, Inc., indicating an approv…
-
CLINICAL_TRIALS trial_result · 2020-07-21Clinical Trial Update: Safety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants With Human Immunodeficiency Virus (HIV) and Hyperlipidemia/Mixed Dyslipidemia [Phase 3]
Phase 3 trial assessing safety, tolerability, and LDL-C reduction with evolocumab in HIV patients with hyperlipidemia/mixed dyslipidemia; co…
-
FDA approval · 2020-07-15FDA Approved: COLESEVELAM HYDROCHLORIDE — Original Application (Cranbury Pharmaceuticals, LLC)
FDA approved the original application for COLESEVELAM HYDROCHLORIDE (colesevelam hydrochloride) by Cranbury Pharmaceuticals, LLC.